Publicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen del Rocío (22)

2023

  1. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  2. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

2021

  1. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608

2020

  1. Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

    Farmacia Hospitalaria, Vol. 44, Núm. 2, pp. 46-50

  2. La farmacotecnia hospitalaria frente a la COVID-19

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 44, Núm. 7, pp. 49-52

2019

  1. A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

    Leukemia Research, Vol. 76, pp. 1-10

2018

  1. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447

2017

  1. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

  2. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead

    Carcinogenesis, Vol. 36, pp. S254-S296

  2. Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort

    European Journal of Nutrition, Vol. 54, Núm. 3, pp. 365-375

  3. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes

    Free Radical Biology and Medicine, Vol. 84, pp. 263-278

2014

  1. Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: A bridge to individualized medicine

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 14, Núm. 4, pp. 305-318

2012

  1. Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH

    Farmacia Hospitalaria, Vol. 36, Núm. 4, pp. 176-179

  2. Comparaciones indirectas, respuesta de los autores

    Farmacia Hospitalaria

2011

  1. Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH

    Farmacia Hospitalaria, Vol. 35, Núm. 3, pp. 140-147

  2. Literature review on the structure and operation of Pharmacy and Therapeutics Committees

    International Journal of Clinical Pharmacy, Vol. 33, Núm. 3, pp. 475-483

  3. Variabilidad en la actividad y los resultados de la evaluación de nuevos medicamentos por las comisiones de farmacia y terapéutica de los hospitales en España

    Farmacia Hospitalaria, Vol. 35, Núm. 6, pp. 305-314